Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.33
NYSE:OMI's Cash-to-Debt is ranked lower than
69% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.74 vs. NYSE:OMI: 0.33 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:OMI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.09 Max: 0.76
Current: 0.33
0
0.76
Equity-to-Asset 0.35
NYSE:OMI's Equity-to-Asset is ranked lower than
63% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. NYSE:OMI: 0.35 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:OMI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.38 Max: 0.47
Current: 0.35
0.21
0.47
Interest Coverage 7.38
NYSE:OMI's Interest Coverage is ranked lower than
60% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.18 vs. NYSE:OMI: 7.38 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:OMI' s Interest Coverage Range Over the Past 10 Years
Min: 6.23  Med: 12.49 Max: 15.45
Current: 7.38
6.23
15.45
Piotroski F-Score: 7
Altman Z-Score: 5.29
Beneish M-Score: -2.58
WACC vs ROIC
7.59%
9.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 2.05
NYSE:OMI's Operating Margin % is ranked lower than
61% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.02 vs. NYSE:OMI: 2.05 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:OMI' s Operating Margin % Range Over the Past 10 Years
Min: 1.69  Med: 2.2 Max: 2.5
Current: 2.05
1.69
2.5
Net Margin % 1.12
NYSE:OMI's Net Margin % is ranked lower than
65% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.12 vs. NYSE:OMI: 1.12 )
Ranked among companies with meaningful Net Margin % only.
NYSE:OMI' s Net Margin % Range Over the Past 10 Years
Min: 0.7  Med: 1.23 Max: 1.36
Current: 1.12
0.7
1.36
ROE % 10.89
NYSE:OMI's ROE % is ranked higher than
51% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.89 vs. NYSE:OMI: 10.89 )
Ranked among companies with meaningful ROE % only.
NYSE:OMI' s ROE % Range Over the Past 10 Years
Min: 6.54  Med: 11.99 Max: 14.35
Current: 10.89
6.54
14.35
ROA % 3.93
NYSE:OMI's ROA % is ranked lower than
52% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. NYSE:OMI: 3.93 )
Ranked among companies with meaningful ROA % only.
NYSE:OMI' s ROA % Range Over the Past 10 Years
Min: 2.63  Med: 5.07 Max: 6.2
Current: 3.93
2.63
6.2
ROC (Joel Greenblatt) % 21.01
NYSE:OMI's ROC (Joel Greenblatt) % is ranked lower than
51% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. NYSE:OMI: 21.01 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:OMI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 16.75  Med: 24.78 Max: 30.56
Current: 21.01
16.75
30.56
3-Year Revenue Growth Rate 3.20
NYSE:OMI's 3-Year Revenue Growth Rate is ranked lower than
62% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.40 vs. NYSE:OMI: 3.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:OMI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0.5  Med: 4.2 Max: 13.5
Current: 3.2
0.5
13.5
3-Year EBITDA Growth Rate 1.70
NYSE:OMI's 3-Year EBITDA Growth Rate is ranked lower than
73% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.50 vs. NYSE:OMI: 1.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:OMI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -1.7  Med: 5.2 Max: 22.7
Current: 1.7
-1.7
22.7
GuruFocus has detected 4 Warning Signs with Owens & Minor Inc $NYSE:OMI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:OMI's 10-Y Financials

Financials (Next Earnings Date: 2017-05-14 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

OMI Guru Trades in Q1 2016

Joel Greenblatt 64,655 sh (New)
David Dreman 217,050 sh (New)
Jim Simons 410,450 sh (+71.84%)
Paul Tudor Jones 22,733 sh (+51.55%)
Barrow, Hanley, Mewhinney & Strauss 158,857 sh (+4.12%)
Mario Gabelli 193,650 sh (unchged)
Charles Brandes Sold Out
Pioneer Investments 578,633 sh (-3.34%)
Chuck Royce 1,148,650 sh (-6.32%)
Keeley Asset Management Corp 43,255 sh (-10.31%)
Richard Pzena 449,414 sh (-56.33%)
» More
Q2 2016

OMI Guru Trades in Q2 2016

Joel Greenblatt 354,994 sh (+449.06%)
Richard Pzena 449,443 sh (+0.01%)
Mario Gabelli 193,650 sh (unchged)
Jim Simons Sold Out
David Dreman Sold Out
Pioneer Investments 578,487 sh (-0.03%)
Barrow, Hanley, Mewhinney & Strauss 158,273 sh (-0.37%)
Keeley Asset Management Corp 39,755 sh (-8.09%)
Chuck Royce 870,350 sh (-24.23%)
Paul Tudor Jones 10,700 sh (-52.93%)
» More
Q3 2016

OMI Guru Trades in Q3 2016

Richard Pzena 942,143 sh (+109.62%)
Keeley Asset Management Corp 39,755 sh (unchged)
Mario Gabelli 193,650 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 576,385 sh (-0.36%)
Barrow, Hanley, Mewhinney & Strauss 155,409 sh (-1.81%)
Chuck Royce 699,000 sh (-19.69%)
Paul Tudor Jones 7,781 sh (-27.28%)
» More
Q4 2016

OMI Guru Trades in Q4 2016

Steven Cohen 83,100 sh (New)
Joel Greenblatt 368,369 sh (New)
Charles Brandes 24,732 sh (New)
Paul Tudor Jones 20,422 sh (+162.46%)
Richard Pzena 1,329,333 sh (+41.10%)
Barrow, Hanley, Mewhinney & Strauss 203,764 sh (+31.11%)
Chuck Royce 717,670 sh (+2.67%)
Pioneer Investments 578,685 sh (+0.40%)
Mario Gabelli 193,650 sh (unchged)
Keeley Asset Management Corp 37,755 sh (-5.03%)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 423450    SIC: 5047
Compare: » details
Traded in other countries:6OM.Germany,
Owens & Minor Inc is a healthcare logistics company that connects the world of medical products to the point of care.

O&M distributes low-tech, consumable medical supplies to acute-care hospitals and other providers. The company distributes thousands of products produced by more than 1,200 suppliers to about 4,000 healthcare providers.

Ratios

vs
industry
vs
history
PE Ratio 19.45
OMI's PE Ratio is ranked higher than
64% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.50 vs. OMI: 19.45 )
Ranked among companies with meaningful PE Ratio only.
OMI' s PE Ratio Range Over the Past 10 Years
Min: 13.54  Med: 20.04 Max: 36
Current: 19.45
13.54
36
Forward PE Ratio 17.99
OMI's Forward PE Ratio is ranked lower than
65% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.08 vs. OMI: 17.99 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 19.45
OMI's PE Ratio without NRI is ranked higher than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.15 vs. OMI: 19.45 )
Ranked among companies with meaningful PE Ratio without NRI only.
OMI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.32  Med: 19.8 Max: 36
Current: 19.45
13.32
36
Price-to-Owner-Earnings 16.53
OMI's Price-to-Owner-Earnings is ranked higher than
50% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.43 vs. OMI: 16.53 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
OMI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6  Med: 17.98 Max: 372.16
Current: 16.53
6
372.16
PB Ratio 2.19
OMI's PB Ratio is ranked higher than
56% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.55 vs. OMI: 2.19 )
Ranked among companies with meaningful PB Ratio only.
OMI' s PB Ratio Range Over the Past 10 Years
Min: 1.79  Med: 2.24 Max: 3.1
Current: 2.19
1.79
3.1
PS Ratio 0.22
OMI's PS Ratio is ranked higher than
84% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.19 vs. OMI: 0.22 )
Ranked among companies with meaningful PS Ratio only.
OMI' s PS Ratio Range Over the Past 10 Years
Min: 0.18  Med: 0.23 Max: 0.29
Current: 0.22
0.18
0.29
Price-to-Free-Cash-Flow 13.39
OMI's Price-to-Free-Cash-Flow is ranked higher than
60% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.81 vs. OMI: 13.39 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
OMI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.38  Med: 18.57 Max: 2771.25
Current: 13.39
5.38
2771.25
Price-to-Operating-Cash-Flow 11.25
OMI's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.16 vs. OMI: 11.25 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
OMI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.92  Med: 14.32 Max: 62.83
Current: 11.25
4.92
62.83
EV-to-EBIT 12.41
OMI's EV-to-EBIT is ranked higher than
63% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.10 vs. OMI: 12.41 )
Ranked among companies with meaningful EV-to-EBIT only.
OMI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8  Med: 11.65 Max: 22.8
Current: 12.41
8
22.8
EV-to-EBITDA 9.68
OMI's EV-to-EBITDA is ranked higher than
65% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.81 vs. OMI: 9.68 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 9.5 Max: 16.4
Current: 9.68
7.1
16.4
PEG Ratio 8.43
OMI's PEG Ratio is ranked lower than
85% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.97 vs. OMI: 8.43 )
Ranked among companies with meaningful PEG Ratio only.
OMI' s PEG Ratio Range Over the Past 10 Years
Min: 0.93  Med: 3.84 Max: 199.71
Current: 8.43
0.93
199.71
Shiller PE Ratio 20.16
OMI's Shiller PE Ratio is ranked higher than
78% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.23 vs. OMI: 20.16 )
Ranked among companies with meaningful Shiller PE Ratio only.
OMI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.5  Med: 22.98 Max: 34.4
Current: 20.16
18.5
34.4
Current Ratio 1.90
OMI's Current Ratio is ranked higher than
63% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. OMI: 1.90 )
Ranked among companies with meaningful Current Ratio only.
OMI' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 1.9 Max: 2.12
Current: 1.9
1.59
2.12
Quick Ratio 1.01
OMI's Quick Ratio is ranked lower than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. OMI: 1.01 )
Ranked among companies with meaningful Quick Ratio only.
OMI' s Quick Ratio Range Over the Past 10 Years
Min: 0.67  Med: 0.95 Max: 1.1
Current: 1.01
0.67
1.1
Days Inventory 40.07
OMI's Days Inventory is ranked higher than
55% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 42.23 vs. OMI: 40.07 )
Ranked among companies with meaningful Days Inventory only.
OMI' s Days Inventory Range Over the Past 10 Years
Min: 34.59  Med: 35.96 Max: 40.07
Current: 40.07
34.59
40.07
Days Sales Outstanding 22.75
OMI's Days Sales Outstanding is ranked higher than
88% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.92 vs. OMI: 22.75 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.19  Med: 22.69 Max: 26.27
Current: 22.75
21.19
26.27
Days Payable 32.10
OMI's Days Payable is ranked lower than
82% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.61 vs. OMI: 32.10 )
Ranked among companies with meaningful Days Payable only.
OMI' s Days Payable Range Over the Past 10 Years
Min: 26.53  Med: 27.93 Max: 32.1
Current: 32.1
26.53
32.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.98
OMI's Dividend Yield % is ranked higher than
80% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. OMI: 2.98 )
Ranked among companies with meaningful Dividend Yield % only.
OMI' s Dividend Yield % Range Over the Past 10 Years
Min: 1.49  Med: 2.52 Max: 3.19
Current: 2.98
1.49
3.19
Dividend Payout Ratio 0.58
OMI's Dividend Payout Ratio is ranked lower than
59% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.32 vs. OMI: 0.58 )
Ranked among companies with meaningful Dividend Payout Ratio only.
OMI' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.48 Max: 0.94
Current: 0.58
0.33
0.94
3-Year Dividend Growth Rate 2.00
OMI's 3-Year Dividend Growth Rate is ranked lower than
84% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.90 vs. OMI: 2.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
OMI' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 2  Med: 12.8 Max: 19.7
Current: 2
2
19.7
Forward Dividend Yield % 3.01
OMI's Forward Dividend Yield % is ranked higher than
76% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.85 vs. OMI: 3.01 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.80
OMI's 5-Year Yield-on-Cost % is ranked higher than
53% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.01 vs. OMI: 3.80 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
OMI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.89  Med: 3.2 Max: 4.05
Current: 3.8
1.89
4.05
3-Year Average Share Buyback Ratio 0.80
OMI's 3-Year Average Share Buyback Ratio is ranked higher than
83% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: -3.00 vs. OMI: 0.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.5  Med: -1.1 Max: 0.8
Current: 0.8
-5.5
0.8

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 10.32
OMI's Price-to-Net-Current-Asset-Value is ranked lower than
83% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.98 vs. OMI: 10.32 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
OMI' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.55  Med: 6.21 Max: 17.64
Current: 10.32
3.55
17.64
Price-to-Tangible-Book 4.56
OMI's Price-to-Tangible-Book is ranked lower than
74% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.84 vs. OMI: 4.56 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
OMI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.72  Med: 4.54 Max: 184.21
Current: 4.56
2.72
184.21
Price-to-Intrinsic-Value-Projected-FCF 1.21
OMI's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
73% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.87 vs. OMI: 1.21 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OMI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.93  Med: 1.34 Max: 2.7
Current: 1.21
0.93
2.7
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.82
OMI's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
78% of the 9 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.40 vs. OMI: 1.82 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.94
OMI's Price-to-Median-PS-Value is ranked higher than
59% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. OMI: 0.94 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OMI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.41  Med: 0.95 Max: 1.1
Current: 0.94
0.41
1.1
Price-to-Graham-Number 1.98
OMI's Price-to-Graham-Number is ranked lower than
62% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.78 vs. OMI: 1.98 )
Ranked among companies with meaningful Price-to-Graham-Number only.
OMI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.36  Med: 1.96 Max: 15.22
Current: 1.98
1.36
15.22
Earnings Yield (Greenblatt) % 8.10
OMI's Earnings Yield (Greenblatt) % is ranked higher than
67% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.35 vs. OMI: 8.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OMI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.4  Med: 8.6 Max: 12.4
Current: 8.1
4.4
12.4
Forward Rate of Return (Yacktman) % 7.31
OMI's Forward Rate of Return (Yacktman) % is ranked lower than
63% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.57 vs. OMI: 7.31 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
OMI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 2.8  Med: 8.9 Max: 20
Current: 7.31
2.8
20

More Statistics

Revenue (TTM) (Mil) $9,723
EPS (TTM) $ 1.76
Beta0.86
Short Percentage of Float22.89%
52-Week Range $30.43 - 41.48
Shares Outstanding (Mil)61.11

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 9,703 9,795 9,954
EPS ($) 1.91 2.03 2.19
EPS without NRI ($) 1.91 2.03 2.19
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.67%
Dividends per Share ($) 1.06 1.19 1.28
» More Articles for NYSE:OMI

Headlines

Articles On GuruFocus.com
Analysts’ Hated Stocks Beat Their Adored Stocks in 2016 Jan 11 2017 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Guru-Held Stocks Near Historical Low P/S Oct 03 2014 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Trading Near Historical Low P/S Ratios Jul 18 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Jun 04 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 20 2014 

More From Other Websites
Owens & Minor (OMI) Reaffirms Tepid 2017 Financial Guidance Mar 17 2017
OWENS & MINOR INC/VA/ Files SEC form 8-K, Regulation FD Disclosure Mar 16 2017
Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018... Mar 16 2017
Owens & Minor Welcomes New EVP of Global Manufacturer Services Mar 13 2017
Owens & Minor, Inc. breached its 50 day moving average in a Bearish Manner : OMI-US : March 7, 2017 Mar 07 2017
OWENS & MINOR INC/VA/ Financials Feb 23 2017
OWENS & MINOR INC/VA/ Files SEC form 10-K, Annual Report Feb 17 2017
Owens & Minor Will Locate Its New Client Engagement Center in Downtown Richmond, Virginia Feb 16 2017
Owens & Minor, Inc. :OMI-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 Feb 16 2017
Owens & Minor, Inc. breached its 50 day moving average in a Bearish Manner : OMI-US : February 16,... Feb 16 2017
Edited Transcript of OMI earnings conference call or presentation 15-Feb-17 1:30pm GMT Feb 15 2017
Owens & Minor, Inc. :OMI-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 Feb 15 2017
OWENS & MINOR INC/VA/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 15 2017
Owens & Minor beats Street 4Q forecasts Feb 14 2017
Owens & Minor beats Street 4Q forecasts Feb 14 2017
Owens & Minor Approves 1st Quarter 2017 Dividend Feb 14 2017
Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results Feb 14 2017
Q4 2016 Owens & Minor Inc Earnings Release - After Market Close Feb 14 2017
OWENS & MINOR INC/VA/ Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Feb 10 2017
Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of... Feb 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)